Cite
New Solid Cancer Data Have Been Reported by Researchers at University of Texas MD Anderson Cancer Center (A Phase Ii Study of Tas-117 In Patients With Advanced Solid Tumors Harboring Germline Pten-inactivating Mutations)
MLA
“New Solid Cancer Data Have Been Reported by Researchers at University of Texas MD Anderson Cancer Center (A Phase Ii Study of Tas-117 In Patients With Advanced Solid Tumors Harboring Germline Pten-Inactivating Mutations).” Obesity, Fitness & Wellness Week, Oct. 2022, p. 1388. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.719509036&authtype=sso&custid=ns315887.
APA
New Solid Cancer Data Have Been Reported by Researchers at University of Texas MD Anderson Cancer Center (A Phase Ii Study of Tas-117 In Patients With Advanced Solid Tumors Harboring Germline Pten-inactivating Mutations). (2022, October 1). Obesity, Fitness & Wellness Week, 1388.
Chicago
Obesity, Fitness & Wellness Week. 2022. “New Solid Cancer Data Have Been Reported by Researchers at University of Texas MD Anderson Cancer Center (A Phase Ii Study of Tas-117 In Patients With Advanced Solid Tumors Harboring Germline Pten-Inactivating Mutations),” October 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.719509036&authtype=sso&custid=ns315887.